思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01244 思路迪医药股份

休市中 10-02 15:57:15

2.790

-0.015

-0.53%

最高2.795	最低2.650	成交量2.10万
今开2.795	昨收2.805	日振幅5.17%
总市值7.20亿	流通市值7.20亿	总股本2.58亿
成交额5.72万	换手率0.01%	流通股本2.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01244","market":"HK","secType":"STK","nameCN":"思路迪医药股份","latestPrice":2.79,"timestamp":1790927835453,"preClose":2.805,"halted":0,"volume":21000,"delay":0,"changeRate":-0.0053475935828877445,"floatShares":258000000,"shares":258000000,"eps":-0.72,"marketStatus":"休市中","change":-0.015,"latestTime":"10-02 15:57:15","open":2.795,"high":2.795,"low":2.65,"amount":57170,"amplitude":0.051693,"askPrice":2.79,"askSize":23500,"bidPrice":2.65,"bidSize":3000,"shortable":0,"etf":0,"ttmEps":-0.773,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":7,"adr":0,"listingDate":1671033600000,"exchange":"SEHK","adjPreClose":2.805,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"volumeRatio":0.4906542044610883,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01244/tweets","defaultTab":"tweets","newsList":[{"id":"1142998259","title":"思路迪医药股份（01244）宣布更换开曼群岛股份过户登记总处地址","url":"https://stock-news.laohu8.com/highlight/detail?id=1142998259","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142998259?lang=zh_cn&edition=full","pubTime":"2026-10-02 12:26","pubTimestamp":1790915189,"startTime":"0","endTime":"0","summary":"思路迪医药股份10月2日发布公告称，公司已于2026年9月30日起变更位于开曼群岛的股份过户登记总处地址，新地址为：Ascentium  Limited，4th Floor, Harbour Place, 103 South Church Street, PO Box 10240, Grand Cayman, KY1-1002, Cayman Islands。同时，卓佳证券登记有限公司继续担任公司香港股份登记及过户分处，其办公地址维持为香港夏悫道16号远东金融中心17楼，投资者如需在香港办理股份过户登记仍应向该处提交申请。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129695017","title":"思路迪医药股份（01244）2026年上半年营收2.11亿元，经调整净亏损0.85亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129695017","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129695017?lang=zh_cn&edition=full","pubTime":"2026-09-30 22:42","pubTimestamp":1790779368,"startTime":"0","endTime":"0","summary":"2026年上半年，思路迪医药股份实现营收2.11亿元，同比上升约0.65%。同期经调整净亏损为0.85亿元，同比扩大约17.45%。毛利率为91.6%，上年同期为92.2%。经营活动所用现金净额为0.55亿元，较上年同期的2.06亿元有所改善。在成本方面，研发开支约为0.63亿元，同比减少约23.8%。行政开支为0.28亿元，相比去年同期有所收窄。报告期内，公司核心商业化产品恩维达贡献收入2.11亿元，占总收入主要部分。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"思路迪医药股份（01244）2026年上半年营收2.11亿元，经调整净亏损0.85亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671822138","title":"港股异动 | mRNA概念股涨幅居前 康希诺生物(06185)涨超17% 莫德纳mRNA新抗原疗法将亮相ESMO大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2671822138","media":"智通财经","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671822138?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:47","pubTimestamp":1790732842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，mRNA概念股涨幅居前，截至发稿，康希诺生物涨16.78%，报36.32港元；云顶新耀涨4.29%，报29.18港元；思路迪医药股份涨1.94%，报2.89港元；剂泰科技-P涨1.44%，报16.22港元。值得注意的是，8月25日，康希诺生物与德普世生物签署《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》。此前在mRNA领域，康希诺生物已布局mRNA 疫苗用于胶质母细胞瘤、横纹肌肉瘤及宫颈癌等适应症的研发。云顶新耀计划在2026年第四季度开展对mRNA疫苗EVM16的 IIT Ib研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01244","BK1583","06185","BK1515","BK4588","VXUS","BK1574","KCAI","07666","01952","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133738510","title":"思路迪医药股份（01244）5000万港元短期票据再度续期至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1133738510","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133738510?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:06","pubTimestamp":1789635961,"startTime":"0","endTime":"0","summary":"2026年9月17日，思路迪医药股份有限公司公告，其全资附属公司思路迪医药科技（香港）有限公司与独立第三方Mega Link International Limited于2026年8月15日签署《短期票据补充协议》，将原定于2026年8月14日到期的短期票据再次续期，新的到期日为2028年8月14日。该票据最初于2023年8月14日签订，本金5,000万港元。依据本次续期协议，自2026年8月15日起至2028年8月14日，票据年利率调整为9%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121158548","title":"思路迪医药股份2026年8月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1121158548","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121158548?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:26","pubTimestamp":1788510401,"startTime":"0","endTime":"0","summary":"思路迪医药股份有限公司于2026年9月4日发布2026年8月股份变动月报表。本次报告期覆盖2026年8月1日至8月31日，相关核心管理层已确认遵守香港联合交易所有限公司的上市规则及相关法律法规要求。报告显示，截至2026年8月31日，公司法定股本结构保持稳定。报告期末已发行股份总数为258,177,000股，库藏股份数量为0股，较上月无变化。在股份变动方面，报告期内未发生新的股份发行、股份购回、注销或库藏股变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004182","title":"思路迪医药股份(01244.HK)上半年实现收入约2.11亿元 全面开启全球化商业布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004182","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663004182?lang=zh_cn&edition=full","pubTime":"2026-08-31 23:10","pubTimestamp":1788189025,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168478487","title":"思路迪医药（01244）公告变更开曼注册办事处地址","url":"https://stock-news.laohu8.com/highlight/detail?id=1168478487","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168478487?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:36","pubTimestamp":1787924173,"startTime":"0","endTime":"0","summary":"2026年8月28日，思路迪医药股份有限公司在港交所发布公告称，自2026年6月16日起，公司于开曼群岛的注册办事处地址已变更为：。Ascentium  Limited，4th Floor, Harbour Place, 103 South Church Street, PO Box 10240, Grand Cayman, KY1-1002, Cayman Islands。公司表示，本次仅涉及注册办事处地址调整，不影响公司的日常运营及管理架构。截至公告日，公司董事会成员包括：执行董事龚兆龙博士；非执行董事张文华女士、周峰先生及陈雅雯女士；独立非执行董事李靖博士、连达鹏博士及刘信光先生。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660702934","title":"思路迪医药股份午前涨超55% 公司在肿瘤赛道布局瞄准国际最前沿方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2660702934","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660702934?lang=zh_cn&edition=full","pubTime":"2026-08-20 11:39","pubTimestamp":1787197140,"startTime":"0","endTime":"0","summary":"模拟交易客户端思路迪医药股份盘初快速飙升，涨幅一度接近130%，截至发稿，股价上涨55.05%，现报3.38港元，成交额874.42万港元。公开资料显示，思路迪医药在肿瘤赛道布局已久，从全球第一款皮下注射PDL1到全球第一款WT1肿瘤疫苗，自建LNP递送系统和AI-肿瘤疫苗筛选平台，In-vivo Car T/NK等都瞄准国际最前沿方向，与全球顶尖肿瘤免疫赛道形成同频共振。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-20/doc-ininxqxt6779426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660706724","title":"港股异动 | 思路迪医药股份(01244.HK)早盘飙升130% 肿瘤免疫治疗迎来里程碑 公司在肿瘤赛道布局瞄准国际最前沿方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2660706724","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660706724?lang=zh_cn&edition=full","pubTime":"2026-08-20 10:51","pubTimestamp":1787194290,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01244","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124447538","title":"港股生物科技股大涨，思路迪医药股份涨超80%，云顶新耀涨超60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124447538","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124447538?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:30","pubTimestamp":1787189405,"startTime":"0","endTime":"0","summary":"8月20日，港股$生物(000504)$科技股大涨，$思路迪医药股份(01244)$涨超80%，$云顶新耀(01952)$涨超60%，$康希诺生物(06185)$涨超50%，$艾美疫苗(06660)$涨超45%，$剂泰科技-P(07666)$涨超25%，$科济药业-B(02171)$涨超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244","BK1191","03034","02834","TTTN","BK4585","VGT","09086","BK1574","BK1515","BK1585","VXUS","BK4588","07522","03086","07568","07666","06660","BK1161","XLK","07261","07266","01952","KCAI","03069","BK1147","02171","06185","09834","BK1583","BK1587","03455"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479489","title":"港股概念追踪|Moderna股价飙升  肿瘤免疫与mRNA技术迎来价值重估（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479489","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660479489?lang=zh_cn&edition=full","pubTime":"2026-08-20 07:28","pubTimestamp":1787182095,"startTime":"0","endTime":"0","summary":"北京时间8月20日，纳斯达克生物科技指数大涨6.39%，创下六年来最大涨幅；Moderna飙升176.97%，市值增加440亿美元；默沙东收涨12.6%，创2009年3月以来最大单日涨幅。智通财经APP获悉，Moderna与默沙东宣布其联合开发的黑色素瘤mRNA癌症疫苗在III期临床中达到主要终点，这一里程碑事件直接引爆了全球医药板块。Moderna的突破验证了mRNA技术在肿瘤治疗领域的商业化潜力，直接提振了整个生物医药赛道的信心。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0819121731.USD","LU1688375341.USD","LU1880383366.USD","02269","LU0051755006.USD","LU0348735423.USD","LU0708995583.HKD","KURE","SG9999002562.SGD","LU3063872942.SGD","LU0359202008.SGD","LU0140636845.USD","LU0326950275.SGD","BK1576","KCAI","LU1242518931.SGD","VXUS","LU0128526141.USD","LU0029874061.USD","BK4585","LU0307460666.USD","LU0516422952.EUR","LU0456846285.SGD","LU0456827905.SGD","LU0979878070.USD","LU0359201612.USD","WDNA","LU0043850808.USD","IE00B0JY6N72.USD","LU0181495838.USD","LU1794554557.SGD","LU0823426308.USD","01244","BK1589","LU0348825331.USD","BK1161","LU0417516738.SGD","LU0516423174.USD","SG9999002463.SGD","LU0588546209.SGD","BK4588","BK1610","LU0516422366.SGD","LU2039709279.SGD","LU0052750758.USD","LU0516422440.USD","LU0856984785.SGD","LU0572944931.SGD","BK1521","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429689","title":"全球首款mRNA肿瘤疫苗三期达标 思路迪医药(01244)涨17%对标国际获重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429689","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660429689?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:16","pubTimestamp":1787148979,"startTime":"0","endTime":"0","summary":"Moderna与默沙东宣布肿瘤新抗原mRNA疫苗mRNA-4157+K药联合辅助治疗黑色素瘤的三期临床INTerpath-001达到主要终点RFS和关键次要终点DMFS。在港股市场，思路迪医药今日收报2.18港元，大涨17.2%，成为板块情绪的核心受益标的之一。在全球肿瘤免疫治疗迈入基因治疗新纪元的当下，思路迪医药凭借差异化的管线布局与商业化节奏，有望持续获得估值重估的催化剂。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01244","BK1161","BK1574","09939","159646","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484451","title":"思路迪医药股份(01244)：已全额收讫SELLAS承担公司产生的相关开支合计798.3万港币","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484451","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660484451?lang=zh_cn&edition=full","pubTime":"2026-08-18 12:47","pubTimestamp":1787028420,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份(01244)发布公告，内容有关公司与SELLAS Life Sciences Group, Inc. (SELLAS)相关争议案件最新进展所发布的公告。独任仲裁员作出最终裁决，全面驳回SELLAS提出的所有仲裁主张，同时裁定SELLAS须承担公司本次仲裁产生的相关开支合计798.3万港币。公司董事会欣然宣布，公司已全额收讫上述款项，本次仲裁裁决款项已足额执行完毕。本次仲裁仅解决双方历史争议，并作出具有最终效力且具约束力的裁决，不会影响许可协议的效力及后续履行。截至目前，3D189全球多中心临床试验(MRCT)已累计完成78例事件，目标终点为80例事件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165250751","title":"思路迪医药（01244.HK）完成近800万港元仲裁裁决款项收取","url":"https://stock-news.laohu8.com/highlight/detail?id=1165250751","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165250751?lang=zh_cn&edition=full","pubTime":"2026-08-18 12:25","pubTimestamp":1787027147,"startTime":"0","endTime":"0","summary":"2026年8月18日，思路迪医药股份有限公司发布自愿公告称，公司已全额收取与SELLAS Life Sciences Group, Inc.仲裁相关的裁决款项，共计7,983,004.42港币。公告回溯显示，2026年7月27日独任仲裁员就双方争议作出最终裁决：驳回SELLAS全部仲裁主张，并裁定SELLAS承担思路迪医药在本案中产生的全部费用7,983,004.42港币。思路迪医药表示，发布本公告旨在向股东及潜在投资者通报最新业务进展，并提醒投资者在买卖公司证券时保持审慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127782129","title":"思路迪医药股份（01244）将于8月31日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1127782129","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127782129?lang=zh_cn&edition=full","pubTime":"2026-08-17 21:31","pubTimestamp":1786973485,"startTime":"0","endTime":"0","summary":"思路迪医药股份（01244）8月17日公告，公司董事会拟于2026年8月31日（星期一）召开会议，主要议程包括：  \n1. 审议截至2026年6月30日止六个月未经审核的中期业绩；  \n2. 考虑派发中期股息（如有）。\n公告显示，董事会成员包括执行董事龚兆龙博士，非执行董事张文华女士、周峰先生及陈雅雯女士，以及独立非执行董事李靖博士、连达鹏博士和刘信光先生。\n公司将于董事会会议后发布相关业绩公告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659299118","title":"创新药概念集体回调 康方生物（09926）跌6.85%、维亚生物（01873）跌6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659299118","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659299118?lang=zh_cn&edition=full","pubTime":"2026-08-14 13:51","pubTimestamp":1786686711,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念集体回调，康方生物 跌6.85%，维亚生物跌6.33%，思路迪医药股份跌6.15%，恒瑞医药跌5.10%，晶泰控股跌4.88%，凯莱英跌4.67%，亚盛医药跌4.04%，药明康德跌3.94%，百济神州跌3.92%。西南证券表示，CXO+创新药放量领涨，8-9月有望迎来业绩+临床数据共振。从产业链的角度，CXO板块投融资改善明显，26H1中国/全球医疗健康投融资分别676.47亿元/2416.43亿元，ADC、多肽、细胞基因治疗等新药物形式赛道持续火热，头部CXO公司海外订单复苏明显。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988233","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0634319403.HKD","01244","LU2778985437.USD","LU0348784397.USD","BK1588","LU2045819591.USD","159992","IE00B5MMRT66.SGD","LU2476274308.USD","LU1251922891.USD","09926","02359","LU0052750758.USD","LU0561508036.HKD","02228","LU1770034418.SGD","01276","LU0228659784.USD","BK1574","LU1720050803.USD","MEDX","LU0348783233.USD","LU1961090484.USD","LU1794554557.SGD","06821","LU0348766576.USD","LNGR","IE00B543WZ88.USD","LU0359202008.SGD","LU0359201612.USD","LU0572944931.SGD","06978","LU1719994722.HKD","06160","BK1617","KURE","BK1576","LU0588546209.SGD","BK1141","IBBQ","LU2476274720.SGD","LU0828237510.HKD","LU0307460666.USD","LU2399975544.HKD","01873","06855","LU0348827113.USD","LU2242644610.SGD","LU0708995583.HKD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195583653","title":"思路迪医药（01244）公布最新董事会及三大委员会构成","url":"https://stock-news.laohu8.com/highlight/detail?id=1195583653","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195583653?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:31","pubTimestamp":1786113068,"startTime":"0","endTime":"0","summary":"2026年8月7日，思路迪医药股份有限公司在港交所披露董事名单及其角色与职能，并公布董事会下设三大委员会最新成员组成。上述任命即时生效。公告显示，思路迪医药董事会现由7名董事构成，其中独立非执行董事占比约43%，符合上市规则对独立性及公司治理结构的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197025949","title":"思路迪医药（01244）董事会调整：朱晋桥辞任，张文华获委任为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1197025949","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197025949?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:22","pubTimestamp":1786112536,"startTime":"0","endTime":"0","summary":"2026年8月7日，思路迪医药股份有限公司公告称，公司董事会已收到朱晋桥先生的辞呈，其非执行董事职务自即日起生效。朱晋桥先生因投身个人事务及发展需要提出辞任，并确认与董事会无意见分歧，亦无其他应提请股东注意的事项。同日，董事会任命张文华女士为非执行董事，任期自2026年8月7日起，为期一年，并将在下一届股东周年大会届满退任并可按公司章程细则续任。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644565","title":"思路迪医药股份(01244)：张文华获任命为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644565","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657644565?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:20","pubTimestamp":1786112407,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份(01244)发布公告，朱晋桥先生已辞任非执行董事，自2026年8月7日起生效，以便投入更多时间于其个人事务及发展。朱晋桥先生退任后，董事会任命张文华女士为非执行董事，自2026年8月7起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139051446","title":"思路迪医药股份2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1139051446","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139051446?lang=zh_cn&edition=full","pubTime":"2026-08-06 15:46","pubTimestamp":1786002373,"startTime":"0","endTime":"0","summary":"思路迪医药股份有限公司于2026年8月6日发布2026年7月股份变动月报表，报告期截至2026年7月31日。根据公告，公司法定注册股本维持在500,000股，对应注册股本总额为港币500,000元。报告期内，已发行普通股为258,177,000股，较上月底无变动。本月公司无新增发行、购回或注销股份，库藏股数量为0；共计已发行及流通在外股份总数维持在258,177,000股不变。本次公告由董事龚兆龙签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3d-medicines.com","stockEarnings":[{"period":"1week","weight":0.043},{"period":"1month","weight":0.1341},{"period":"3month","weight":0.1434},{"period":"6month","weight":-0.3195},{"period":"1year","weight":-0.656},{"period":"ytd","weight":-0.4765}],"compareEarnings":[{"period":"1week","weight":-0.0219},{"period":"1month","weight":-0.0529},{"period":"3month","weight":0.0266},{"period":"6month","weight":-0.0456},{"period":"1year","weight":-0.1215},{"period":"ytd","weight":-0.0647}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。该公司专注于肿瘤慢病化治疗领域的创新药物发现、开发及商业化，同时布局肿瘤疼痛管理领域。该公司已经构建一套完整的公司内部研发体系，已实现了从药物发现，临床前开发，临床试验、注册的全流程覆盖。该公司第一款上市药物恩维达是一款用于治疗泛瘤种的皮下注射PD-L1抑制剂。该公司还拥有多项创新药研发管线。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.034607},{"month":2,"riseRate":0.75,"avgChangeRate":0.110633},{"month":3,"riseRate":0.25,"avgChangeRate":0.037641},{"month":4,"riseRate":0.25,"avgChangeRate":-0.031877},{"month":5,"riseRate":0.5,"avgChangeRate":0.043316},{"month":6,"riseRate":0.25,"avgChangeRate":-0.039804},{"month":7,"riseRate":0.25,"avgChangeRate":-0.021803},{"month":8,"riseRate":0.5,"avgChangeRate":-0.109835},{"month":9,"riseRate":0.5,"avgChangeRate":-0.067423},{"month":10,"riseRate":0,"avgChangeRate":-0.196677},{"month":11,"riseRate":0,"avgChangeRate":-0.194469},{"month":12,"riseRate":0.666667,"avgChangeRate":0.250685}],"exchange":"SEHK","name":"思路迪医药股份","nameEN":"3D MEDICINES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供思路迪医药股份(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"思路迪医药股份,01244,思路迪医药股份股票,思路迪医药股份股票老虎,思路迪医药股份股票老虎国际,思路迪医药股份行情,思路迪医药股份股票行情,思路迪医药股份股价,思路迪医药股份股市,思路迪医药股份股票价格,思路迪医药股份股票交易,思路迪医药股份股票购买,思路迪医药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供思路迪医药股份(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}